Compumedics Limited (AU:CMP) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Compumedics Limited has announced a significant boost to their European operations with a $1 million sale of their state-of-the-art Okti neurological wireless amplifier to two leading epilepsy hospitals in Berlin. This new technology has driven a 63% increase in FY24 sales in Europe, solidifying Compumedics’ position in the competitive neurological diagnostic market, which in Europe alone is estimated to be worth up to EUR 300 million with a growth rate of 10% per annum.
For further insights into AU:CMP stock, check out TipRanks’ Stock Analysis page.